Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2012
06/14/2012US20120148572 Novel antibodies
06/14/2012US20120148571 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and uses thereof
06/14/2012US20120148568 Variant Immunoglobulins with Improved Manufacturability
06/14/2012US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/14/2012US20120148549 Method to isolate, identify, and use embryonic stem cells directed to forebrain interneuron fate
06/14/2012US20120148490 Anti-ngf compositions and use thereof
06/14/2012US20120145588 Method for improving compliance with a treatment regimen for treating or preventing osteoporosis
06/14/2012DE102010062600A1 Hydrophobisiertes Proteinhydrolysat Hydrophobized protein hydrolyzate
06/14/2012CA2820671A1 Tnf-.alpha. binding proteins
06/14/2012CA2820134A1 Human monoclonal antibody
06/14/2012CA2820039A1 Immunoassay of cofilin 1 protein
06/13/2012EP2462237A1 Methods for improving recombinant protein expression
06/13/2012EP2462224A1 Method for producing nucleases of a gram negative bacterium while using a gram positive expression host
06/13/2012EP2124548B1 Disintegrin variants and pharmaceutical uses thereof
06/13/2012EP1597382B1 Genetically modified non-human mammals and cells
06/13/2012EP1495053B1 Angiopoietin-2 and angiopoietin-1 specific binding agents
06/13/2012EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins
06/13/2012EP0904288B1 Vaccine comprising the pathogenic escherichia coli associated protein espa
06/13/2012EP0451216B2 Humanized immunoglobulins and their production and use
06/13/2012CN1606567B Antimicrobial polypeptides from pseudoplectania nigrella
06/13/2012CN1483831B Process for obtaining insulin and insulin derivatives having correctly bonded crystine bridges
06/13/2012CN102498217A Antibodies specific to E6 proteins of HPV and use thereof
06/13/2012CN102492761A Method for preparing active polypeptide from fish pomace
06/13/2012CN102492760A Method for producing active Rana dybowskii collagen oligopeptide by using compound enzyme
06/13/2012CN102492759A Method for preparing soluble corn peptide from Aspergillus niger fermented maize yellow powder
06/13/2012CN102492758A Method for preparing Caspase-3 activation peptide by phycocyanin
06/13/2012CN102492639A Mutant capable of raising cyclic lipopeptides antibiotic output by using RNA polymerase mutation, its preparation method and its application
06/13/2012CN102488713A Method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrated solution
06/13/2012CN101993888B Method for producing and recombining main allergic protein Hum j 3 of Humulus scandens by induced secretion expression
06/13/2012CN101970639B Microorganism producing cyclic compound
06/13/2012CN101875699B Fusion protein of human epidermal growth factor and metallothionein and preparation method and application thereof
06/13/2012CN101775406B Recombinant protein expression and purification with functions of preventing and treating atherosclerosis
06/13/2012CN101570574B Anti-I type Shiga toxin IgY antibody as well as preparation method and use thereof
06/13/2012CN101343315B Shorten human papilloma virus 6 type L1 protein
06/12/2012USRE43472 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor
06/12/2012US8198424 Use of flagellin in the immunotherapy of Yersinia pestis
06/12/2012US8198416 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
06/12/2012US8198413 Anti-CD151 antibodies and their use in the treatment of cancer
06/12/2012US8198412 Antibodies that recognize cutting edge within the TGF-β activation controlling region
06/12/2012US8198407 Sequential protein isolation and purification schemes by affinity chromatography
06/12/2012US8198242 Variants of C-type natriuretic peptide
06/12/2012US8198084 Serum-free mammalian cell culture medium, and uses thereof
06/12/2012US8198078 Fucosyl transferase gene
06/12/2012US8198067 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins
06/12/2012US8198049 Nucleic acids encoding RUP3 and methods of using same
06/12/2012US8198047 RGD containing recombinant gelatin
06/12/2012US8198046 KEX2 cleavage regions of recombinant fusion proteins
06/12/2012US8198045 Expression of O-glycosylated therapeutic proteins in prokaryotic microorganisms
06/12/2012US8198043 Two helix binders
06/12/2012US8197827 Protein from Photobacterium damselae and use thereof
06/12/2012US8197824 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same
06/12/2012US8197822 Method for the production of human immunodeficiency virus (HIV) proteins utilizing modified vaccinia virus ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)
06/12/2012US8197820 HIV-1 Tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/12/2012US8197814 Method for treating the Th2-mediated disease
06/12/2012US8197813 Human antibodies that bind human TNFα
06/12/2012CA2634269C Novel peptide-forming enzyme gene
06/12/2012CA2502385C Il-1 receptor based antagonists and methods of making and using
06/12/2012CA2288992C Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
06/12/2012CA2262756C A tumor necrosis factor related ligand
06/12/2012CA2249746C Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
06/12/2012CA2218526C Structure-based designed herbicide resistant products
06/12/2012CA2214830C Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
06/12/2012CA2180473C Cloning and characterization of h.pylori flba gene. production of aflagellate strains
06/12/2012CA1341631C Nucleic acid encoding the alpha or beta chains of inhibin and method forsynthesizing polypeptides using such nucleic acid
06/07/2012WO2012075045A2 Release factor 1 (rf1) in escherichia coli
06/07/2012WO2012074948A2 Surface, anchored fc-bait antibody display system
06/07/2012WO2012074130A1 Peptide library production method, peptide library, and screening method
06/07/2012WO2012074129A1 Peptide with safer secondary structure, peptide library, and production methods for same
06/07/2012WO2012074097A1 Anti-cd33 antibody
06/07/2012WO2012074029A1 Polynucleotide construct capable of presenting fab in acellular translation system, and method for manufacturing and screening fab using same
06/07/2012WO2012073992A1 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
06/07/2012WO2012073987A1 E. coli transformant, production method for flavin-bound glucose dehydrogenase using same, and mutant flavin-bound glucose dehydrogenase
06/07/2012WO2012073986A1 Flavin-bound glucose dehyrogenase, production method for flavin-bound glucose dehyrogenase, and yeast transformant used in same
06/07/2012WO2012071649A1 Covalently dimerized bivalent binding agents
06/07/2012WO2012037285A3 Methods and compositions for targeting heterologous integral membrane proteins to the cyanobacterial plasma membrane
06/07/2012US20120142901 Purification method which prevents denaturation of an antibody
06/07/2012US20120142895 Host cells and methods of use
06/07/2012US20120142891 Fusion protein systems suitable for high expression of peptides
06/07/2012US20120142761 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm
06/07/2012US20120142611 Repeat protein from collection of repeat proteins comprising repeat modules
06/07/2012US20120142595 Tissue protective peptides and uses thereof
06/07/2012US20120142593 Factor VIII Variants and Methods of Use
06/07/2012US20120142079 Minicell based delivery of biologically active compounds
06/07/2012US20120142057 Method for production of polypeptide
06/07/2012US20120142056 MAMMALIAN EXPRESSION VECTOR pUHAB
06/07/2012US20120142055 Targeted integration into the ppp1r12c locus
06/07/2012US20120142054 Srsv detection kit
06/07/2012US20120142053 Method for methanol independent induction from methanol inducible promoters in pichia
06/07/2012US20120142052 Method and device for multiple feed cultivation
06/07/2012US20120142051 Transcription regulatory factors for mannanases or cellulases, and genes for the transcription regulatory factor
06/07/2012US20120142050 Novel expression vector
06/07/2012US20120142049 Recombinant Gene Expression
06/07/2012US20120142048 Nucleic acid which is stabilized against decomposition
06/07/2012US20120142047 Purification and Separation Treatment Assembly (PASTA) for Biological Products
06/07/2012US20120142029 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
06/07/2012US20120142022 Glycosylated mammalian ngal and use thereof
06/07/2012US20120142015 Gfp fusion proteins and their use
06/07/2012US20120142007 Stable compositions for nucleic acid amplification and sequencing
06/07/2012US20120141529 Norovirus and sapovirus antigens
06/07/2012US20120141522 Recombinant protective protein from streptococcus pneumoniae
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 1125